Detalhe da pesquisa
1.
Akt signaling is critical for memory CD8+ T-cell development and tumor immune surveillance.
Proc Natl Acad Sci U S A
; 114(7): E1178-E1187, 2017 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28137869
2.
Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation.
Blood
; 127(4): 449-57, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26491071
3.
CD8+ T-cell cross-competition is governed by peptide-MHC class I stability.
Eur J Immunol
; 42(1): 256-63, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22002320
4.
Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies.
JCI Insight
; 7(19)2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998045
5.
Epithelial to mesenchymal transition influences fibroblast phenotype in colorectal cancer by altering miR-200 levels in extracellular vesicles.
J Extracell Vesicles
; 11(5): e12226, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595718
6.
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.
J Exp Clin Cancer Res
; 41(1): 131, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392965
7.
Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoid.
Eur J Immunol
; 40(4): 976-85, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20104490
8.
LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation.
JCI Insight
; 5(18)2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870822
9.
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression.
Cancer Immunol Res
; 7(11): 1876-1890, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31451483
10.
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell-Driven Antitumor Immunity.
Clin Cancer Res
; 24(10): 2383-2394, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29514845
11.
Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression.
Aging (Albany NY)
; 9(12): 2666-2694, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29283887
12.
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment.
Cancer Cell
; 32(6): 777-791.e6, 2017 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29198913
13.
Vaccination with DNA encoding a single-chain TCR fusion protein induces anticlonotypic immunity and protects against T-cell lymphoma.
Cancer Res
; 62(6): 1757-60, 2002 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11912151
14.
Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
J Clin Oncol
; 34(34): 4132-4141, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863190
15.
Upregulated Glucose Metabolism Correlates Inversely with CD8+ T-cell Infiltration and Survival in Squamous Cell Carcinoma.
Cancer Res
; 76(14): 4136-48, 2016 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27206847
16.
Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation.
J Invest Dermatol
; 134(3): 695-703, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24005050
17.
Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide-MHC class I complexes.
Eur J Immunol
; 38(2): 364-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18196518
18.
Prolonged antigen expression following DNA vaccination impairs effector CD8+ T cell function and memory development.
J Immunol
; 179(12): 8313-21, 2007 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056376
19.
Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.
J Immunol
; 177(10): 6626-33, 2006 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17082574
20.
DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
Immunol Rev
; 199: 156-80, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15233733